Cargando…
Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769102/ https://www.ncbi.nlm.nih.gov/pubmed/34507323 http://dx.doi.org/10.1097/CM9.0000000000001695 |
| _version_ | 1784635055850651648 |
|---|---|
| author | Gao, Tiantao Liu, Xinghong Shen, Qi Luo, Zhu Feng, Ping Miao, Jia Zheng, Li Chen, Donglin Xiang, Jin |
| author_facet | Gao, Tiantao Liu, Xinghong Shen, Qi Luo, Zhu Feng, Ping Miao, Jia Zheng, Li Chen, Donglin Xiang, Jin |
| author_sort | Gao, Tiantao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8769102 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87691022022-01-20 Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma Gao, Tiantao Liu, Xinghong Shen, Qi Luo, Zhu Feng, Ping Miao, Jia Zheng, Li Chen, Donglin Xiang, Jin Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-01-20 2021-09-09 /pmc/articles/PMC8769102/ /pubmed/34507323 http://dx.doi.org/10.1097/CM9.0000000000001695 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Gao, Tiantao Liu, Xinghong Shen, Qi Luo, Zhu Feng, Ping Miao, Jia Zheng, Li Chen, Donglin Xiang, Jin Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title | Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title_full | Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title_fullStr | Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title_full_unstemmed | Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title_short | Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma |
| title_sort | pharmacokinetics and bioequivalence evaluation of lenalidomide in chinese patients with multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769102/ https://www.ncbi.nlm.nih.gov/pubmed/34507323 http://dx.doi.org/10.1097/CM9.0000000000001695 |
| work_keys_str_mv | AT gaotiantao pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT liuxinghong pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT shenqi pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT luozhu pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT fengping pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT miaojia pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT zhengli pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT chendonglin pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma AT xiangjin pharmacokineticsandbioequivalenceevaluationoflenalidomideinchinesepatientswithmultiplemyeloma |